Michael Organ is a Full Professor at the University of Ottawa's Department of Chemistry and Biomolecular Sciences, affiliated with the Faculty of Science. He also serves as Director of the Centre for Research and Innovation in Catalysis. His research focuses on catalysis, flow chemistry, and medicinal chemistry, emphasizing sustainable and efficient synthesis methods. Organ has held adjunct roles at the University of Toronto and has extensive industry collaborations, including with GlaxoSmithKline and Abbvie. Education: PhD (University of Guelph, 1992), MSc (University of Guelph, 1988), Hons. BSc (University of Guelph, 1986). Research Interests: Catalysis, microwave-assisted continuous synthesis, reactive intermediates in flow systems, and drug discovery methodologies. His work bridges organic chemistry with engineering, developing scalable and green processes. Publications & Impact: Over 200 publications, including seminal works in Journal of the American Chemical Society and Chemistry – A European Journal . Key contributions include the Pd-PEPPSI-IPent catalyst and the MACOS flow chemistry platform. Awards: NSERC John C. Polanyi Award (2018), Encyclopedia of Reagents Best Reagent Award (2017), Raymond Lemieux Award (2016). Recognized internationally for catalytic innovations. Grants & Funding: Over $45M in research funding, including NSERC Discovery Grants and industry partnerships. Notable projects include CFI JELF grants for sustainable manufacturing and pandemic-related flow chemistry for SARS-CoV-2 diagnostics. Labs & Teams: Leads the Organ Group, collaborating with chemical engineers and industry partners. Specializes in reactor design, catalyst development, and continuous processing systems.
جستجوی استاد راهنمای دانشگاهی
برای مسیر پژوهشیتان، استاد راهنما، استاد دانشگاه و پژوهشگر مناسب را پیدا کنید و با آنها ارتباط بگیرید.
نمایش ۱-۱۵ از ۳۲ استاد راهنما
اطلاعات پروفایلها از صفحات عمومی دانشگاهها گرفته شده و ممکن است بهروز نباشد.
- Organic Chemistry
- Flow Chemistry
- Green Chemistry
- +۴ مورد دیگر
Professor Steven V. Ley leads the Yusuf Hamied Department of Chemistry at the University of Cambridge, focusing on transformative research in flow chemistry, organic synthesis, and green chemistry. His work emphasizes sustainable methodologies and the integration of advanced technologies like microcontrollers and automation to revolutionize chemical processes. In 2018, he received the prestigious Arthur C. Cope Award—the first UK-based recipient—recognizing groundbreaking contributions to organic chemistry. Research interests include developing continuous flow systems for hazardous reaction management, immobilized reagents, and machine-assisted synthesis. Collaborations span academia and industry, notably through spin-off company New Path Molecular , which applies cutting-edge synthesis techniques to pharmaceuticals and agrochemicals. Key publications highlight innovations in flow chemistry applications, sustainable process design, and automation. His work bridges chemistry with engineering, aiming to address global challenges in resource efficiency and environmental impact. Awards: Arthur C. Cope Award (2018) Lab/Teams: Active research group at the University of Cambridge; collaborates with New Path Molecular on commercial applications.
Maria Solerمشاهده پروفایل
پژوهشگر
- Nanophotonics
- Biosensors
- Nanoplasmonics
- +۵ مورد دیگر
Dr. Maria Soler serves as a Senior Researcher at the Catalan Institute of Nanoscience and Nanotechnology (ICN2), conducting pioneering work in the Nanobiosensors and Bioanalytical Applications group (NanoB2A) under the Networking Research Center of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN). Her expertise spans nanophotonic biosensor development for real-time, label-free detection in complex biomedical environments. Her academic credentials include: PhD in Biochemistry, Molecular Biology and Biomedicine from Autonomous University of Barcelona (2015, with distinguished honors) Postdoctoral research at Ecole Polytechnique Federale de Lausanne (EPFL, Switzerland) for 3 years Dr. Soler's research integrates optical biosensor development , nanoplasmonics , and surface chemistry with molecular biology to create diagnostic platforms for immunology and personalized medicine. The NanoB2A group focuses on nanoplasmonic biosensors, silicon nanophotonic systems, lab-on-a-chip integration, and surface biofunctionalization, targeting clinical diagnostics and environmental applications through interdisciplinary innovation. Her publication trends reveal consistent advancement in label-free photonic biosensors for precision diagnostics, particularly in point-of-care testing for infectious diseases (including multiple SARS-CoV-2 applications) and cancer immunotherapy monitoring. This work bridges nanotechnology fundamentals with urgent healthcare needs, demonstrating exceptional translational potential in pandemic response and personalized treatment strategies. Dr. Soler's contributions have been recognized through distinguished PhD honors and features in Laser Focus World, though specific awards remain unlisted in available materials. Her research has secured significant ERDF funding for laboratory enhancements within the Biodeposition and Biodetection Unit (U4 NANBIOSIS). As leader of the NanoB2A laboratory at ICN2, she oversees cutting-edge equipment for nanobiosensor development and application, recently upgraded through European Regional Development Fund investments to advance diagnostic capabilities for complex biomedical challenges.
Agata Gitlin-Domagalskaمشاهده پروفایل
استاد مدعو
Dr. Agata Gitlin-Domagalska serves as an Adjunct Professor at the Faculty of Chemistry, University of Gdańsk, where she leads research in the Department of Molecular Biochemistry and Laboratory of Bioorganic Chemistry. Her work bridges peptide chemistry and bioorganic drug design, focusing on innovative synthetic strategies and therapeutic applications. Academic Affiliation: Faculty of Chemistry, University of Gdańsk Department: Department of Molecular Biochemistry Laboratory: Laboratory of Bioorganic Chemistry Specializing in peptide synthesis and prodrug development , Dr. Gitlin-Domagalska investigates strategies to enhance oral bioavailability of charged peptides through lipophilic charge masking and non-covalent inhibition of serine proteases like matriptase and furin . Her research extends to antimicrobial peptide conjugates with dual therapeutic functions and Zika virus suppression via protease inhibition. Recent publications highlight her expertise in peptide splicing mechanisms , solid-phase synthesis optimization , and nanoparticle-based delivery . She has developed cyclic RGD prodrugs for targeted intestinal permeability and bicyclic furin inhibitors using combinatorial chemistry approaches. Her work contributes to antibiotic conjugates with leukemia-selective antifungal activity , neuroprotective humanin analogs , and vasopressin derivatives with expanded therapeutic potential. Current trends emphasize matriptase-selective inhibitors and earthworm-derived antimicrobial nanoparticles . Dr. Gitlin-Domagalska employs model membrane biosensing for drug-membrane interaction studies and has pioneered high-shear mixing techniques to improve amide bond formation efficiency in peptide synthesis processes.
Rebecca J. Whelan is an Associate Professor in the Department of Chemistry at the University of Kansas, specializing in bioanalytical chemistry. With appointments in both the Chemistry and Bioengineering programs, her research focuses on ovarian cancer biomarker analysis through proteomics, microscale separations, and affinity reagent development. B.A. Chemistry and English, Lawrence University (1996) Ph.D. Chemistry, Stanford University (2003) Postdoctoral Research Fellow, Bioanalytical Chemistry, University of Michigan (2003-2004) Research Interests: The Whelan Lab develops innovative analytical methods for cancer biomarker characterization, including: Structural analysis of CA125 (MUC16) using long-read sequencing and mass spectrometry Development of DNA aptamers as artificial antibodies for biomarker detection Microscale separation techniques (capillary electrophoresis) for clinical proteomics Biosensor development for point-of-care diagnostics Integration of bioinformatics with experimental validation Sample preparation methods for glycoprotein analysis Scientific Awards: Vice Chair-Elect, Gordon Research Conference on Bioanalytical Sensors (2022) Henry Dreyfus Teacher-Scholar Award (2011) W.M. Keck Foundation Fellowship (2008) Research Corporation, Cottrell College Science Award (2006) Walter J. Gores Award for Teaching Excellence (1999) Teaching and Funding: Whelan has received multiple teaching honors including the Professor Props Award finalist. Her lab receives funding from the National Cancer Institute, National Science Foundation, and Dreyfus Foundation. She co-directed the T32 Chemical Biology training program and received the Newmark Award for biochemical research excellence.
Kate O'Connor-Giles is a Provost's Professor of Brain Science at Brown University, affiliated with the Department of Neuroscience and the Carney Institute for Brain Science. Her research focuses on understanding synaptic communication and plasticity in neurons, employing advanced techniques like genetics, electrophysiology, and CRISPR-based genome engineering. She leads the O'Connor-Giles Lab, which develops innovative tools for studying synapses in vivo and contributes to open-access resources like the CRISPR Target Finder and FlyCRISPR platforms. Her work bridges molecular mechanisms and functional outcomes, investigating how neurons build and modulate synaptic connections over time. Key areas include autophagy regulation at ER-lysosome interfaces, transcriptional control of synaptic genes, and the role of calcium channels in synaptic diversity. The lab’s CRISPR tools have significantly advanced Drosophila genetics research, enabling precise genome editing and homology-directed repair. Publications highlight interdisciplinary approaches, from synaptic growth mechanisms to neurodegenerative pathways, emphasizing the interplay between molecular biology and neuronal function. Her lab’s reagents are shared via Addgene and the Drosophila Genomics Resource Center, fostering collaborative research globally.
Christine Saluzzo is a Professor at the University of Maine 's Faculty of Sciences , affiliated with the Institute of Molecules and Materials of Le Mans (UMR CNRS 6283). Her expertise spans asymmetric catalysis, polymer-supported catalysis, and organic synthesis methodology. PhD in Organic Chemistry (1989), Lyon I University Postdoctoral work (1990) at Texas A&M University Lecturer at Lyon I University (1990-2002) University Professor at University of Maine since 2002 Her research focuses on asymmetric heterogeneous catalysis , particularly with polymer-anchored nitrogenous ligands , enabling enantioselective hydrogenations, hydrogen transfer reductions, and cross-coupling reactions. She has developed chiral catalysts derived from isosorbide and BINAP for pharmaceutical and materials applications. Recent publications highlight enantioselective Friedel-Crafts alkylations , fluorinated immunostimulatory agents , and chiral polyamino alcohol ligands . Her work emphasizes sustainable catalytic systems and biologically relevant compound synthesis. She has co-authored multiple patents on chiral polymers and ligands, and contributed chapters to books on polymer-supported catalysis and asymmetric synthesis. Collaborations with Marc Lemaire and Stéphane Guillarme underpin her catalysis research.
Hernan D. Biava is an Associate Professor of Chemistry at Brevard College, with expertise spanning biochemistry, biocatalysis, asymmetric synthesis, and inorganic chemistry. His research focuses on enzyme engineering, vibrational spectroscopy, and fluorine chemistry applications. Ph.D. in Chemistry, National University of Rosario B.S. in Chemistry, National University of Rosario His recent work explores the development of fluorinated biocatalysts, asymmetric organic synthesis using biomass-derived materials, and the application of vibrational Stark spectroscopy to study enzyme electrostatics. Collaborations include institutions in Germany and Argentina. Notable scientific awards include the Georg Forster Prize (2011) from the Alexander von Humboldt Foundation and the Enrique Herrero Ducloux Prize (2010) from the Argentinean Chemical Association. Earlier accolades include multiple doctoral prizes from French institutions.
Duane Juangمشاهده پروفایل
استادیار
Duane Juang serves as Assistant Professor of Engineering in Biology at Brandeis University, where he bridges engineering, chemistry, and biology to develop accessible tools for health research and diagnostics through novel assay platforms. Education: BS from National Tsing Hua University, Taiwan PhD from National Tsing Hua University, Taiwan PhD from University of Wisconsin-Madison His research program focuses on creating simple tools using physical phenomena (fluidics, magnetics) and chemistries (surface, biomolecular) for biological discovery. Key initiatives include: developing high-throughput microbial screening for antibiotic discovery, studying microbial community interactions for therapeutic applications like Clostridium difficile infection treatment, and engineering point-of-care diagnostics with quantum magnetic sensing for low-abundance biomarker detection without complex instrumentation. Analysis of his recent publications reveals consistent advancement in microfluidic technologies for health applications, spanning microbial ecology platforms, enzymatic reaction acceleration, and integrated diagnostic systems for pathogens. His work demonstrates a translational approach from fundamental microbial studies to practical diagnostic solutions addressing global health challenges. As director of the In Vitro Methods Lab, Dr. Juang fosters interdisciplinary collaboration to harness emerging technologies for accessible health solutions, with ongoing projects targeting antibiotic discovery pipelines and field-deployable diagnostic tools for resource-limited settings.
Keith J. Stine is a Professor and Department Chair in the Department of Chemistry and Biochemistry at the University of Missouri–St. Louis (UMSL), within the College of Arts and Sciences. He has been a faculty member since 1990 and plays a significant leadership role in the university, having previously served as Chair of the Faculty Senate and University Assembly. His educational background includes a BS from Fairleigh Dickinson University and a PhD from MIT, followed by postdoctoral training at UCLA. Dr. Stine's research is centered on modified surfaces and nanostructures, particularly nanoporous gold, with applications in bioanalytical chemistry, sensors, immunoassays, and separations. He investigates surface immobilization of proteins, lipid monolayers as cell membrane models, and carbohydrate-protein interactions. His work integrates electrochemical methods such as impedance spectroscopy and cyclic voltammetry with advanced characterization techniques like SEM, TEM, AFM, and gas adsorption analysis. The 15 most recent publications highlight a strong trend in the development and application of nanostructured materials, especially nanoporous gold, for drug delivery, biosensing, and glycan synthesis. There is a clear interdisciplinary focus spanning materials science, electrochemistry, glycochemistry, and biomedical applications, often in collaboration with the Demchenko lab at Saint Louis University. While no formal scientific awards are listed in the provided text, his extensive publication record in high-impact journals reflects significant scholarly contributions. Dr. Stine actively mentors students and researchers, with numerous co-authors on recent papers indicating a vibrant research group. He has been involved in projects related to grants in nanomaterials, bioanalytical chemistry, and carbohydrate synthesis, though specific grant details are not provided. His research contributes to both fundamental science and translational applications in diagnostics and therapy. His laboratory focuses on the synthesis and characterization of functional nanostructures, particularly for biomedical applications. The team explores hierarchical architectures in nanoporous metals, electrochemical biosensors, and automated carbohydrate synthesis, working at the intersection of chemistry, materials science, and biology.
Arundhati Nagمشاهده پروفایل
دانشیار
Arundhati Nag is an Associate Professor of Chemistry at Clark University, leading research in synthetic chemistry and biomedical applications. Her work focuses on peptide macrocycles for cancer therapeutics, biomimetic catalysis, and biomolecule sensing. She holds a Ph.D. from the California Institute of Technology (2013), an M.S. from the Indian Institute of Technology (2006), and a B.S. from Presidency College, University of Calcutta (2004). Her research themes include: Cancer Therapeutics: Developing macrocyclic peptides targeting protein-protein interactions (PPIs) in cancer pathways. Biomimetic Catalysis: Creating copper/peptide complexes mimicking photosynthetic enzymes for water oxidation and CO 2 reactions. Biomolecule Sensors: Designing macrocyclic reagents for selective detection of phosphorylated metabolites and amyloid beta aggregates. Recent publications highlight advancements in copper-selective sensors, click chemistry catalysts, and cyclic peptide libraries. Her work has been supported by grants from the National Science Foundation (CAREER Award), Research Corporation for Science Advancement (Cottrell Scholar Award), and the American Chemical Society. Awards: Cottrell Scholar Award (Research Corporation for Science Advancement) Grants: National Science Foundation: CAREER Award (2022–2027) NIH: Development of inhibitors for KRAS-G12V/SOS interactions (2020–2024) Her lab emphasizes interdisciplinary approaches, integrating organic synthesis, biochemistry, and materials science to address biomedical challenges.
Soran Maria Loredana is a Principal Researcher (CS I, R4) at the National Institute for Research and Development of Isotopic and Molecular Technologies (RO) , focusing on analytical chemistry, environmental science, and nanomaterial synthesis. She serves as Project Coordinator and PhD Supervisor , with a ResearcherID Q-9581-2019 . MSc in Organometallic and Coordination Chemistry (1999) PhD in Chemistry (2005) Habilitated in Environmental Engineering (2018) Her research spans superabsorbent materials for water recycling , microwave effects on plant metabolites , and eco-friendly nanomaterial synthesis , with applications in drought mitigation, antibiotic resistance reduction, and sustainable agriculture. Current projects integrate nanotechnology with climate adaptation strategies. Key methodologies include HPLC/TLC chromatography , spark plasma sintering , and biochar functionalization , emphasizing international collaboration across Turkey, Israel, Moldova, and Italy. Her work addresses global water scarcity and pollution challenges through innovative material design. As a scientific reviewer and educator, she contributes to research integrity and human resource development. Her laboratory at Cluj-Napoca investigates core-shell nanoparticles, surface science standards, and bioactive compound extraction technologies.
Paul R Hansonمشاهده پروفایل
استاد آموزشی
Paul R. Hanson is the Chancellors Club Teaching Professor in the Department of Chemistry at the University of Kansas (KU). He leads the Hanson Research Group,which focuses on developing synthetic methods for drug discovery and natural product synthesis, particularly utilizing transition metal-catalyzed approaches to create S- and P-heterocycles. His research emphasizes immobilized reagents and phosphate-tethered strategies for polyol synthesis and complex molecule construction. Education: B.A. from Luther College (1985), Ph.D. from the University of Minnesota (1993), followed by NIH postdoctoral training at Stanford University (1993–1996). Research interests include synthetic methodology development, heterocyclic chemistry, and medicinal applications of complex organic molecules. His work bridges traditional organic synthesis with modern combinatorial techniques, enabling efficient generation of diverse compound libraries. Key contributions include phosphate-tether-mediated total syntheses of natural products like Sanctolide A and Dolabelide C. Publications highlight innovations in metathesis-driven cyclization, immobilized reagent systems, and polyol synthesis strategies. The lab’s efforts are supported by grants from NIH and other agencies, focusing on drug delivery mechanisms and anticancer agents. Hanson’s research group is housed in the Integrated Science Building (ISB) and Strong Hall, collaborating with KU’s chemistry department and industry partners. They actively engage in training students through the KU Chemistry Club and ACS Student Chapter.
Maria Isabel Romero Garcia is a full Professor in the Department of Chemistry at the Faculty of Sciences, University of Girona (UdG), Spain. She holds a PhD from the Autonomous University of Barcelona and has been a faculty member at UdG since 1996, advancing from Assistant to Associate and then to full Professor in 2018. Her academic career includes significant postdoctoral experience in France, contributing to her expertise in inorganic and catalytic chemistry. Education: BSc in Chemistry, University of Murcia (1989) Master’s in Chemistry, University of Murcia (1990) PhD in Chemistry, Autonomous University of Barcelona (1995) Her research focuses on Sustainable Redox Catalysis using coordination compounds and the Heterogenization and Reusability of Catalytic Systems . She has made notable contributions to photoredox catalysis with ruthenium and metallacarborane compounds, particularly in aqueous-phase oxidation reactions. Her work bridges fundamental inorganic chemistry with practical applications in green and sustainable processes. The 15 most recent publications reflect a consistent trajectory in inorganic and organometallic catalysis , emphasizing sustainability, reusability, and biomimetic design. Key themes include photoredox systems, heterogenized catalysts, and the use of boron and silver complexes. Her publications appear in top journals such as JACS, Angewandte Chemie, and Green Chemistry, showcasing the high impact of her work. She has been recognized through extensive research leadership, including coordination of the doctoral and master's programs in Homogeneous Catalysis at UdG. She has also served on scientific committees for major conferences like QIES12, QIES14, and EUROBORON9. Scientific contributions and service include: Principal Investigator in 7 public R&D projects Member of scientific committees for international conferences Reviewer for AGAUR (Catalonia), ANPCyT (Argentina), and international journals External reviewer for doctoral theses Jury member for over 25 doctoral defenses and academic hiring processes Maria Isabel Romero has supervised 8 completed PhD theses and currently mentors 2 more, along with numerous master’s and undergraduate students. She has participated in 35 funded R&D projects and holds 2 published patents with one pending. She is also involved in the Erasmus+ KA107 mobility program, promoting international academic exchange. Her research group contributes to the Analytical and Environmental Chemistry Research Group at UdG. She has presented her work on boron salts for antimicrobial resistance at public outreach events and participated in technology transfer activities such as the EBTON Conference (2023). Her laboratory integrates synthetic inorganic chemistry with catalytic testing and material characterization, aiming to develop environmentally friendly chemical processes.
Paweł Borowieckiمشاهده پروفایل
استادیار
Paweł Borowiecki is an Assistant Professor at the Chair of Drug and Cosmetics Biotechnology , Faculty of Chemistry, Warsaw University of Technology. His research focuses on biocatalysis and asymmetric synthesis of pharmaceuticals and chiral compounds using enzymes like lipases and alcohol dehydrogenases . He leads the Biocatalysis and Biotransformation Laboratory and has contributed to 44 publications, 1 patent, and 6 projects. Education : Doctorate in Chemical Sciences (2016) His work spans medicinal chemistry , green synthesis , and industrial biocatalysis , with recent studies on photo-biocatalytic redox systems and dynamic kinetic resolution of secondary alcohols. Key trends in his 2023-2025 publications include sustainable methods for synthesizing anticancer agents , antivirals , and cardiovascular drugs . Collaborations include researchers from DSM Nutritional Products, University of Graz, and Polish Academy of Sciences. His lab integrates computational methods (molecular docking) with experimental biocatalysis.